Research map: The psychosocial burden of chronic hand eczema: reflections on its assessment and methodological limitations

Back to the article

Papers in this map

  1. EuroQol - a new facility for the measurement of health-related quality of life · The EuroQol Group · 1990 · 16023 citations · Cited by this paper
  2. Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years · 2026 · Related
  3. Information bias in health research: definition, pitfalls, and adjustment methods · Alaa Althubaiti · 2016 · 3112 citations · Cited by this paper
  4. Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial · 2026 · Related
  5. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results · M.K.A. Basra · 2008 · 796 citations · Cited by this paper
  6. Early response to ivarmacitinib and its impact on long-term efficacy in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of a phase-III trial · 2026 · Related
  7. Construct validity and responsiveness of the Colombian version of Skindex‐29 · Daniel Vásquez · 2019 · 21 citations · Cited by this paper
  8. Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort study · 2026 · Related
  9. Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream · Timo Buhl · 2025 · 4 citations · Cited by this paper
  10. Effect of methotrexate on endothelial function in psoriasis patients · 2026 · Related
  11. Health-related quality of life in individuals with Chronic hand eczema – Findings from the multinational CHECK study · Anthony Bewley · 2026 · 1 citation · Cited by this paper
  12. Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis · 2026 · Related
  13. Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials · 2026 · Related
  14. Distinct ocular safety profiles of dupilumab and upadacitinib in atopic dermatitis: a real-world study with ophthalmological and microbiological assessment · 2026 · Related
  15. Recalcitrant tinea infections due to Trichophyton indotineae in the United States (2025–2026): a retrospective case series identified by real-time PCR · 2026 · Related

Source: OpenAlex (CC0)